---
title: HIV Patients Cohort
nct_id: NCT02203006
overall_status: ACTIVE_NOT_RECRUITING
phase: NA
sponsor: Assistance Publique - Hôpitaux de Paris
study_type: INTERVENTIONAL
primary_condition: Patients Affected by the HIV
countries: France
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02203006.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02203006"
ct_last_update_post_date: 2026-05-06
last_seen_at: "2026-05-12T06:40:49.213Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# HIV Patients Cohort

**Official Title:** Constitution of an Open Monocentric Cohort of HIV Infected Patients

**NCT ID:** [NCT02203006](https://clinicaltrials.gov/study/NCT02203006)

## Key Facts

- **Status:** ACTIVE_NOT_RECRUITING
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 1613
- **Lead Sponsor:** Assistance Publique - Hôpitaux de Paris
- **Collaborators:** URC-CIC Paris Descartes Necker Cochin
- **Conditions:** Patients Affected by the HIV
- **Start Date:** 2011-10-19
- **Completion Date:** 2030-11-19
- **CT.gov Last Update:** 2026-05-06

## Brief Summary

The purpose of this study is to improve our knowledge concerning HIV infection, treated or not, in the current conditions of care to optimize it.

## Detailed Description

Since the arrival of highly active tritherapies, HIV infection became mainly an ambulatory chronic pathology centred on a long term care taking into account the complication of long-term treatment as well as the arisen of new problem bound to a prolonged survival and ageing. So the care is more and more in a prevention and screening approach with in particular the care of metabolic and cardiovascular complication due to antiretroviral treatment.

As a reorganization of the coverage of the HIV infected people take place on the Hotel Dieu Hospital it thus seems important to double this care optimization with a clinical research side. This will be done in constituting an HIV patient cohort including a blood sample collection to contribute to the vigilance of the complication to due the infection.

Our ultimate objective is to optimize the selection of the treatment. It is important to do it to be able to have, on many years duration, precise clinical information and biological sample allowing to realize later some assay and analyse the influence of some genetic markers.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Aged ≥18 years old,
* Patients with an HIV infection
* patients having given their written informed consent.
```

## Arms

- **OVIHD** (OTHER) — Cohort and a blood sample collection will be done with data and blood of HIV infected patients

## Interventions

- **OVIHD** (BIOLOGICAL) — 7 ml of blood will be taken during a follow-up consultation and kept in a biological collection. Clinical data will be collected in a database.

## Primary Outcomes

- **HIV infection** _(time frame: 10 years)_ — The HIV cohort will be constituted in collecting cardiovascular, neurological clinical data and medical past history (in case of women patient)

## Secondary Outcomes

- **Comorbidity and complication in HIV infected patients** _(time frame: 10 years)_
- **efficiency of the current antiretroviral therapeutic diets** _(time frame: 10 years)_
- **Blood sample collection** _(time frame: 10 years)_

## Locations (1)

- Hôpital Hôtel Dieu, Paris, France

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.hôpital hôtel dieu|paris||france` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02203006.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02203006*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*